Disease/Infection News

RSS

Scientists develop a cell-free assay to screen SARS-CoV-2 entry inhibitors

Scientists have developed and validated a cell-free fluorescence assay for the rapid screening of protein inhibitors.

7 Oct 2021

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.

7 Oct 2021

After 5 months, Pfizer-BioNTech COVID vaccine remains highly protective against hospitalization and death

The study "Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study" is published in the journal The Lancet.

7 Oct 2021

Large study of COVID vaccine side effects in Sweden

Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.

6 Oct 2021

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

A new study published on the medRxiv* preprint server focused on a patient with a persistent symptomatic viral infection for over a year. Researchers amplified sub-genomic transcripts for the E gene (sgE) using nasopharyngeal samples of the patient infected with SARS-CoV-2 over the course of 335 days.

6 Oct 2021

New model can predict the risk of airborne COVID-19 infection in offices and schools

As more UK workers and students return to offices and schools, a new model has been developed to predict the risk of airborne COVID-19 infection in such environments.

6 Oct 2021

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

A new study, published on the medRxiv* preprint server, suggested that selective pressures induced by the administration of monoclonal antibodies (Bamlanivimab) may require increased genomic surveillance to identify and control the spread of therapy-induced variants.

6 Oct 2021

Novel proteomics approach predicts severe COVID-19 outcomes

Researchers in the United States, Canada, and the UK have developed a potential new approach to predicting severe and critical outcomes among patients with coronavirus disease 2019 (COVID-19).

6 Oct 2021

COVID-19 lockdown restrictions may increase preterm stillbirths

Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.

6 Oct 2021

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

A new study posted to the medRxiv* server and led by Dr. Mattia D'Agostino, Dr. Eleonora Pavoni and Dr. Alice Romagnoli from the Polytechnic University of Marche in Ancona (Italy), a gFET biosensor that uses angiotensin-converting enzyme 2 (ACE2) as a bioreceptor has been put forth as a viable solution.

6 Oct 2021

Does vaccination prevent long COVID?

In a recent study, researchers evaluate the effect of COVID-19 vaccination on a large ongoing prospective cohort of patients with long COVID.

6 Oct 2021

Moderna COVID vaccine booster dose results in immune memory

A recent study presents evidence that a booster dose of the Moderna vaccine can induce a robust memory immune response against COVID-19.

6 Oct 2021

Research on twins indicates strong genetic influences in COVID-19

A new study discusses the strong possibility of multifactorial causation for SARS-CoV-2 infection using data from twin studies.

6 Oct 2021

COVID-19 pandemic may have promoted unhealthy eating in the U.K.

A new study discusses dietary changes as a result of the pandemic.

6 Oct 2021

Durability of immunity to SARS-CoV-2 reinfection

The current study used data on the durability of immunity among evolutionarily close coronavirus relatives of SARS-CoV-2 to estimate times to reinfection.

6 Oct 2021

Characteristics of unvaccinated individuals from the University of Southern California

A recent study examines the characteristics of university staff and faculty who remained unvaccinated against COVID-19.

6 Oct 2021

Study finds increased risk for SARS-CoV-2 breakthrough infections in people with substance use disorders

An analysis of electronic health records of nearly 580,000 fully vaccinated people in the United States found that the risk of SARS-CoV-2 breakthrough infection among vaccinated patients with substance use disorders was low overall, but higher than the risk among vaccinated people without substance use disorders.

6 Oct 2021

Disease/Infection News

Scientists develop a cell-free assay to screen SARS-CoV-2 entry inhibitors

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

After 5 months, Pfizer-BioNTech COVID vaccine remains highly protective against hospitalization and death

Large study of COVID vaccine side effects in Sweden

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

New model can predict the risk of airborne COVID-19 infection in offices and schools

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

Novel proteomics approach predicts severe COVID-19 outcomes

COVID-19 lockdown restrictions may increase preterm stillbirths

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

Does vaccination prevent long COVID?

Moderna COVID vaccine booster dose results in immune memory

Research on twins indicates strong genetic influences in COVID-19

COVID-19 pandemic may have promoted unhealthy eating in the U.K.

Durability of immunity to SARS-CoV-2 reinfection

Characteristics of unvaccinated individuals from the University of Southern California

Study finds increased risk for SARS-CoV-2 breakthrough infections in people with substance use disorders

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

Enisamium shows potential as antiviral therapy for COVID-19

Study shows strong protective effect of IgG3 antibodies in SARS-CoV-2 infection

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News